{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:58Z","timestamp":1791298498931,"version":"4.1.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,1,26]]},"DOI":"10.18632\/oncotarget.6915","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T05:06:05Z","timestamp":1452747965000},"page":"3709-3725","source":"Crossref","is-referenced-by-count":19,"title":["Cooperative TRAIL production mediates IFN\u03b1\/Smac mimetic-induced cell death in TNF\u03b1-resistant solid cancer cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Stefanie","family":"Roesler","sequence":"first","affiliation":[{"name":"Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Eckhardt","sequence":"additional","affiliation":[{"name":"Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt, Germany"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fulda","sequence":"additional","affiliation":[{"name":"Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Frankfurt, Germany"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Vucic","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","article-title":"IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis","volume":"131","author":"Deshayes","year":"2007","journal-title":"Cell"},{"key":"3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","article-title":"IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis","volume":"131","author":"Tergaonkar","year":"2007","journal-title":"Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccr.2007.08.029","article-title":"Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis","volume":"12","author":"Wang","year":"2007","journal-title":"Cancer Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-physiol-021113-170259","article-title":"Control of life-or-death decisions by RIP1 kinase","volume":"76","author":"Yuan","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","article-title":"Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use","volume":"89","author":"Belardelli","year":"2007","journal-title":"Biochimie"},{"key":"7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cytogfr.2014.10.006","article-title":"High efficiency targeting of IFN-alpha activity: possible applications in fighting tumours and infections","volume":"26","author":"Tavernier","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/leu.2010.324","article-title":"Interferon-alpha in acute myeloid leukemia: an old drug revisited","volume":"25","author":"Smits","year":"2011","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.canlet.2014.08.040","article-title":"Synergistic interaction of Smac mimetic and IFNalpha to trigger apoptosis in acute myeloid leukemia cells","volume":"355","author":"Fulda","year":"2014","journal-title":"Cancer Lett"},{"key":"10","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1073\/pnas.1005667107","article-title":"Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1158\/1078-0432.CCR-09-1125","article-title":"Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas","volume":"15","author":"Mueller","year":"2009","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1200\/JCO.2005.05.2498","article-title":"Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses","volume":"24","author":"Kirkwood","year":"2006","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2011.41.3799","article-title":"Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma","volume":"30","author":"de Schaetzen","year":"2012","journal-title":"J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.2806","article-title":"Smac mimetics and innate immune stimuli synergize to promote tumor death","volume":"32","author":"Ilkow","year":"2014","journal-title":"Nat Biotechnol"},{"key":"15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.1211623","article-title":"Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-alpha but not through TRAIL and FasL","volume":"92","author":"Kamat","year":"2012","journal-title":"J Leukoc Biol"},{"key":"16","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2013.52.3993","article-title":"Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1128\/JVI.79.14.9320-9324.2005","article-title":"Identification of TRAIL as an interferon regulatory factor 3 transcriptional target","volume":"79","author":"Howley","year":"2005","journal-title":"J Virol"},{"key":"18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jir.2012.0110","article-title":"Interferons as inducers of apoptosis in malignant cells","volume":"33","author":"Gamero","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"e936","DOI":"10.1038\/cddis.2013.457","article-title":"Identification of DR5 as a critical, NF-kappaB-regulated mediator of Smac-induced apoptosis","volume":"4","author":"Fulda","year":"2013","journal-title":"Cell Death Dis"},{"key":"20","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-13-2376","article-title":"Molecular pathways: targeting death receptors and smac mimetics","volume":"20","author":"Fulda","year":"2014","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-15-0365","article-title":"Promises and Challenges of Smac Mimetics as Cancer Therapeutics","volume":"21","author":"Fulda","year":"2015","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4471-6458-6_8","article-title":"Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand (TRAIL)","volume":"818","author":"Fulda","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"23","first-page":"5s","article-title":"Pharmacodynamic biomarkers from phase II study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-mimetic birinapant (TL32711; NSC 756502) in relapsed platinum-resistant epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC) (NCT01681368)","volume":"32","author":"Kohn","year":"2014","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"e1893","DOI":"10.1038\/cddis.2015.234","article-title":"Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines","volume":"6","author":"Tang","year":"2015","journal-title":"Cell Death Dis"},{"key":"25","first-page":"3823","article-title":"The CD95 (APO-1\/Fas) system mediates drug-induced apoptosis in neuroblastoma cells","volume":"57","author":"Debatin","year":"1997","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2011.353","article-title":"RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis","volume":"26","author":"Fulda","year":"2012","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.440","article-title":"Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma","author":"Fulda","year":"2015","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1038\/cddis.2013.70","article-title":"Identification of non-canonical NF-kappaB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells","volume":"4","author":"Fulda","year":"2013","journal-title":"Cell Death Dis"},{"key":"29","first-page":"61","volume-title":"Synergism and antagonism in chemotherapy","author":"Chou","year":"1991"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:37:01Z","timestamp":1589218621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,1,26]]}},"alternative-id":["6915","26788912"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6915","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}